TrialDiabetes, obesity & metabolism2011

LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects.

P Barrington et al.PubMed ↗Publisher ↗

No numbers read from the abstract.